Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2012
12/27/2012DE102011105469A1 7-Azaindolderivate 7-azaindole derivatives
12/27/2012CA2839703A1 Trpm8 antagonists and their use in treatments
12/27/2012CA2839699A1 Trpm8 antagonists and their use in treatments
12/27/2012CA2837727A1 Substituted imidazopyridinyl-aminopyridine compounds
12/26/2012EP2537830A1 Compounds and compositions as protein kinase inhibitors
12/26/2012EP2536714A2 A novel 5-membered heterocycle derivatives and manufacturing process thereof
12/26/2012EP2536713A1 (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
12/26/2012EP2536711A1 5-ht receptor modulators
12/26/2012EP2536710A2 Piperidine derivatives
12/26/2012EP2536706A1 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
12/26/2012EP2536698A1 Isoxazoline derivatives as insecticides
12/26/2012EP2536283A1 Phenyl-heteroaryl derivatives and methods of use thereof
12/26/2012CN102844309A Processes for the preparation of rivaroxaban and intermediates thereof
12/26/2012CN102838591A Melamine compound and method for preparing the same
12/26/2012CN101730703B Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof
12/26/2012CN101648923B Hydroxamic acid compound used as histone deacetylase inhibitor and application thereof
12/26/2012CN101626765B Transcription factor modulating compounds and methods of use thereof
12/26/2012CN101466678B Substituted 3-cyanopyridines as protein kinase inhibitors
12/25/2012USRE43878 Amidophenoxyindazoles useful as inhibitors of c-Met
12/25/2012US8338614 e.g. 2-[5-(5-methyl-1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazol-2-yl]-1-phenylpropan-2-amine; neurodegenerative diseases; preventing the formation of insoluble amyloid beta and arresting the production of amyloid beta
12/25/2012US8338595 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
12/25/2012US8338592 Fused thiazole derivatives as kinase inhibitors
12/25/2012US8338591 3-aryl-5,6-disubstituted pyridazines
12/25/2012US8338469 Compounds and compositions as channel activating protease inhibitors
12/25/2012US8338459 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/25/2012US8338440 Inhibitors of IAP
12/25/2012US8338419 N-thio-anthranilamid compounds and their use as pesticides
12/25/2012US8338418 Dual-acting antihypertensive agents
12/25/2012US8338416 Indole derivatives as inhibitors of histone deacetylase
12/25/2012US8338415 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
12/25/2012US8338414 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
12/25/2012US8338401 Coumarin-amide derivatives and its preparation, said drug composition and its use
12/20/2012WO2012173682A2 Compounds and methods for the treatment of isocitrate dehydrognase related diseases
12/20/2012WO2012173174A1 Azaspiroalkane compound
12/20/2012WO2012171506A1 Compounds, their pharmaceutical compositions and their uses as idh1 mutants inhibitors for treating cancers
12/20/2012WO2012171479A1 Oxazolidinone compounds and their uses in preparation of antibiotics
12/20/2012WO2012171343A1 Novel method for synthesizing rivaroxaban intermediate, 4-{4-[(5s)-5-(aminomethyl)-2-oxo-1,3-oxazoligdin-3-yl]phenyl}morpholin-3-one
12/20/2012WO2012171246A1 Novel method for synthesizing rivaroxaban intermediate, 4-{4-[(5s)-5-(aminomethyl)-2-oxo-1,3-oxazoligdin-3-yl]phenyl}morpholin-3-one
12/20/2012US20120323006 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
12/20/2012US20120323003 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
12/20/2012US20120322827 Compounds and methods
12/20/2012US20120322819 Compound containing a novel 4-alkoxypyrimidine structure and medicine containing same
12/20/2012US20120322804 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
12/20/2012US20120322803 Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
12/20/2012US20120322802 Novel 2, 4-pyrimidine derivatives and use thereof
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322800 Sepiapterin Reductase Inhibitors For The Treatment of Pain
12/20/2012US20120322799 Deuterated compounds useful for treating neurodegenerative diseases
12/20/2012US20120322795 Biarylamide inhibitors of leukotriene production
12/20/2012US20120322787 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
12/20/2012US20120322785 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
12/20/2012US20120322784 Compounds, pharmaceutical compositions and uses thereof
12/20/2012CA2839616A1 Therapeutically active compositions and their methods of use
12/19/2012EP2535336A1 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
12/19/2012EP2534139A1 Novel aminoalkyl-oxazole and aminoalkyl-thiazole carboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue
12/19/2012EP2533783A1 Compounds and methods
12/19/2012CN102834384A Oxazine derivative
12/19/2012CN102834382A Pyrazole derivatives as modulators of calcium release-activated calcium channel
12/19/2012CN102827155A Oxazolidinone compounds and application of oxazolidinone compound in preparation of antibiotic medicine
12/19/2012CN102827154A New method for synthesizing rivaroxaban intermediate 4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidine-3-yl]phenyl}morpholine-3-ketone
12/19/2012CN102827153A Crystal form of azilsartan and preparation method thereof
12/19/2012CN102827097A Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug
12/19/2012CN102827095A Benzoxazine resin mid-body containing arylamine and preparation method thereof
12/19/2012CN102827078A Condensed-cyclic compound and organic light-emitting diode comprising the same
12/19/2012CN101790514B 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
12/18/2012US8334378 Thiazolyl-dihydro-quinazoline compounds and processes for preparing same
12/18/2012US8334309 Heterocyclic indazole derivatives
12/18/2012US8334296 2,4-pyrimidinediamine compounds and their uses
12/18/2012US8334290 CETP inhibitors
12/18/2012US8334236 Ring-fused 2-pyridone derivatives and herbicides
12/18/2012CA2719721C Tetrahydroisoquinoline derivative
12/18/2012CA2671776C Gal3 receptor antagonists for the treatment of depression
12/18/2012CA2577758C Gyrase inhibitors and uses thereof
12/18/2012CA2517517C P38 inhibitors and methods of use thereof
12/13/2012WO2012170976A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
12/13/2012WO2012170867A1 Novel compounds as modulators of gpr-119
12/13/2012WO2012170702A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
12/13/2012WO2012170554A1 N-biphenylmethylindole modulators of pparg
12/13/2012WO2012170035A1 Surfactants with a terminal dialkyl- or cycloalkyl-substituted tertiary amine and inks including the same
12/13/2012WO2012169649A1 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
12/13/2012WO2012168350A1 Pyridin- 2 -amides useful as cb2 agonists
12/13/2012WO2012168315A1 Substituted piperidines as gpr119 modulators for the treatment of metabolic disorders
12/13/2012WO2012168265A1 Substituted benzamide derivatives
12/13/2012WO2012168260A1 Pyrazole derivatives
12/13/2012WO2012168226A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
12/13/2012WO2012168175A1 [1,3]oxazines
12/13/2012WO2012168164A1 Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors
12/13/2012WO2011156554A8 Cyclohexyl-azetidinyl antagonists of ccr2
12/13/2012US20120316336 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
12/13/2012US20120316201 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/13/2012US20120316193 Proteostasis regulators
12/13/2012US20120316173 Compounds which modulate the cb2 receptor
12/13/2012US20120316172 Pyrazole derivatives
12/13/2012US20120316171 Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
12/13/2012US20120316170 Imidazole Derivative
12/13/2012US20120316169 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
12/13/2012US20120316168 Quinolone compound and pharmaceutical composition
12/13/2012US20120316167 Secondary 8-hydroxyquinoline-7-carboxamide derivatives
12/13/2012US20120316165 Substituted benzamide derivatives
12/13/2012US20120316162 Piperidine and piperazine derivatives
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 647